EcoDrugPlus

Ensembl ID : ENSMOCG00000015851
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSMOCG00000003289
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSMOCG00000002638
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSMOCG00000006881
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSMOCG00000008046
Gene Symbol: -
Cross references: -
61 Possible Orthologues:

Ensembl ID : ENSMOCG00000019458
Gene Symbol: -
Cross references: -
81 Possible Orthologues:

Ensembl ID : ENSMOCG00000017944
Gene Symbol: -
Cross references: -
602 Possible Orthologues:

Ensembl ID : ENSMOCG00000017924
Gene Symbol: -
Cross references: -
38 Possible Orthologues:

Ensembl ID : ENSMOCG00000006379
Gene Symbol: -
Cross references: -
635 Possible Orthologues:

Ensembl ID : ENSMOCG00000013633
Gene Symbol: -
Cross references: -
275 Possible Orthologues:

Ensembl ID : ENSMOCG00000012985
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSMOCG00000002429
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).